Oruka Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024
Period Ending	Dec '25 Dec 5, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,493	679
Enterprise Value	994	325
Last Close Price	30.84	19.39
PB Ratio	3.08	1.78
P/TBV Ratio	3.09	1.79
Debt / Equity Ratio	0.00	0.00
Quick Ratio	16.65	28.80
Current Ratio	16.94	28.89
Return on Capital Employed (ROCE)	-25.60%	-24.90%
Earnings Yield	-4.88%	-13.46%
FCF Yield	-6.02%	-9.33%

Source: S&P Capital IQ. Standard template. Financial Sources.